The ovarian cancer is responsible for killing 1 women in every two hours. The treatment of this deadly cancer has been difficult due to the failure of the current tests to detect it on the timely basis. The newer test introduces revolutionary methods, which can detect the disease twice as quickly as other methods.
In the trial run the test was able to provide exceptional results where the disease was detected even in those women who show the earliest sign of the disease. The test is under further trial to discover if it would be able to distinguish between people who have higher risk of cancer due to genetic disorders.
The current tests in the market failed to detect the earlier signs of the cancer that can prove to be life saving for the individuals and provide them with increased protection against the disease. The developers of the test exclaimed that they are eager to provide this test to the public so that thousands of women around the world can lead a healthier and safer life.
Only a 3rd of the population suffering from the ailment can survive disease primarily because of difficulty to identify and detect the disease in its early stages. If the disease is caught early it is possible to treat it in 90% of the cases, but the surviving rate drops in the advanced cases.
The newer test would be able to save countless lives due to its advance detection features that should be able to detect the disease at an earlier stage.